Europe Extracellular Matrix Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Raw Material (Bovine, Porcine, and Other Raw Material), Application (Soft Tissue Repair, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, and Vascular Repair and Reconstruction)
The Europe extracellular matrix market is expected to reach US$ 15,712.1 Thousands by 2028 from US$ 9,301.4 Thousands in 2021. The market is estimated to grow at a CAGR of 7.8% from 2021–2028.
The rise in the treatment for musculoskeletal diseases is also expected to drive market growth. The studies have shown positive extracellular matrix results to treat various cancers as it plays an essential role in restraining the growth of the cancer cells. Most cell behavior and developmental processes are targeted to regulate the cancer cells. Thus, the benefits of the extracellular matrix enable treating cancer effectively, and the rising number of cases cancer cases are likely to demand extracellular matrix. Thus, the market is likely to grow significantly during the forecast period due to the factors mentioned above.
The pandemic has enforced the research institutes and pharmaceutical companies to develop effective drug therapies for treatment of covid-19 thus, the market is expected to witness slow growth during the forecast period. Moreover, due to countrywide lockdowns and restrictions most of surgical procedures across the regions got postponed and delayed thus resulted in lack of demand for extracellular matrix derived products. Moreover, The COVID-19 outbreak is likely to impact the extracellular matrix market in the initial phase of the forecast period. Owing to nationwide lockdowns, denied wound care services, postponed or canceled elective surgeries, delays in clinical trials for novel therapies etc. Thus, the pandemic is expected to have a negative impact on market growth during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the extracellular matrix market. The Europe extracellular matrix market is expected to grow at a good CAGR during the forecast period.
Europe Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousands)
Europe Extracellular Matrix Market Segmentation
By Raw Material
- Bovine
- Porcine
- Others
By Application
- Soft Tissue Repair
- Dural Repair
- Wound Healing
- Cardiac Repair
- Pericardial Repair
- Vascular Repair and Reconstruction
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Medtronic
- Merck Kgaa
- Smith & Nephew
- Anteris
- Coloplast Group
- Baxter
- DSM
- Cook Biotech
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Extracellular Matrix Market – By Raw Material
1.3.2 Europe Extracellular Matrix Market – By Application
1.3.3 Europe Extracellular Matrix Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Extracellular Matrix Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. Extracellular Matrix Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Significantly Rising Incidences of Trauma & Cardiovascular Diseases
5.1.2 Increasing Vascular Reconstruction Procedures
5.2 Market Restraints
5.2.1 Challenges During the Usage of Decellularized Extracellular Matrix
5.3 Market Opportunities
5.3.1 Growth Opportunities in the Developing Nations
5.4 Future Trends
5.4.1 Benefits of Treating Cancer
5.5 Impact Analysis
6. Extracellular Matrix Market– Europe Analysis
6.1 Europe Extracellular Matrix Market Revenue Forecast and Analysis
7. Extracellular Matrix Market Revenue and Forecasts To 2028 – Raw Material
7.1 Overview
7.2 Europe Extracellular Matrix Market Share by Raw Material - 2020 & 2028 (%)
7.3 Porcine
7.3.1 Overview
7.3.2 Porcine: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
7.4 Bovine
7.4.1 Overview
7.4.2 Bovine: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
7.5 Others
7.5.1 Overview
7.5.2 Others: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
8. Extracellular Matrix Market Analysis – By Application
8.1 Overview
8.2 Europe Extracellular Matrix Market, By Application, 2020 & 2028 (%)
8.3 Soft Tissue Repair
8.3.1 Overview
8.3.2 Soft Tissue Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.4 Dural Repair
8.4.1 Overview
8.4.2 Dural Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.5 Wound Healing
8.5.1 Overview
8.5.2 Wound Healing: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.6 Cardiac Repair
8.6.1 Overview
8.6.2 Cardiac Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.7 Pericardial Repair
8.7.1 Overview
8.7.2 Pericardial Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.8 Vascular Repair and Reconstruction
8.8.1 Overview
8.8.2 Vascular Repair and Reconstruction: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
9. Europe Extracellular Matrix Market – Geographic Analysis
9.1 Europe: Extracellular Matrix Market Revenue and Forecasts to 2028
9.1.1 Overview
9.1.2 Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.3 Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.1.4 Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5 Europe: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
9.1.5.1 Germany: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.1.1 Germany: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.1.2 Germany: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.1.3 Germany: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2 France: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2.1 France: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2.2 France: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2.3 France: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.3 UK: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.3.1 UK: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.3.2 UK: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.3.3 UK: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.4 Italy: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.4.1 Italy: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.4.2 Italy: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.4.3 Italy: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.5 Spain: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.5.1 Spain: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.5.2 Spain: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.5.3 Spain: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.6 Rest of Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.6.1 Rest of Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.6.2 Rest of Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.6.3 Rest of Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
10. Impact of COVID-19 Pandemic on Europe Extracellular Matrix Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Extracellular Matrix Market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 MERCK KGaA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Smith & Nephew
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Anteris
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Coloplast Group
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Baxter
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 DSM
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Cook Biotech Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 2. Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Germany: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 4. Germany: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. France: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 6. France: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. UK: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 8. UK: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Italy: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Italy: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Spain: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Spain: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Rest of Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Rest of Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Organic Developments Done By Companies
Table 16. Inorganic Developments Done By Companies
Table 17. Glossary of Terms, Extracellular Matrix Market
LIST OF FIGURES
Figure 1. Extracellular Matrix Market Segmentation
Figure 2. Europe Extracellular Matrix Market Overview
Figure 3. Porcine Segment Held Largest Share by Raw Material Segment in Extracellular Matrix Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe Extracellular Matrix Market, Industry Landscape
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to Extracellular Matrix Market
Figure 9. Europe Extracellular Matrix Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. Europe Extracellular Matrix Market Share by Raw Material - 2020 & 2028 (%)
Figure 11. Porcine: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 12. Bovine: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 13. Others: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 14. Europe Extracellular Matrix Market, By Application, 2020 & 2028 (%)
Figure 15. Soft Tissue Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 16. Dural Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 17. Wound Healing: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 18. Cardiac Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 19. Pericardial Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 20. Vascular Repair and Reconstruction: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 21. Europe: Extracellular Matrix Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 22. Europe: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 23. Europe: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
Figure 24. Germany: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 25. France: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. UK: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Italy: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Spain: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 29. Rest of Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Impact of COVID-19 Pandemic in European Country Markets
Figure 31. Growth Strategies in the Extracellular Matrix Market
- Medtronic
- Merck Kgaa
- Smith & Nephew
- Anteris
- Coloplast Group
- Baxter
- DSM
- Cook Biotech
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe extracellular matrix market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe extracellular matrix market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.